EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Interim safety review of PVX108 peptide immunotherapy in an ongoing Phase 2 trial in peanut-allergic adolescents and children

Friday 31 May, 12:00 PM - 12:00 PM Valencia, Spain